GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (OTCPK:NSHSF) » Definitions » Total Liabilities

NSHSF (Nanosphere Health Sciences) Total Liabilities : $1.71 Mil (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Nanosphere Health Sciences Total Liabilities?

Nanosphere Health Sciences's Total Liabilities for the quarter that ended in Sep. 2024 was $1.71 Mil.

Nanosphere Health Sciences's quarterly Total Liabilities increased from Mar. 2024 ($1.60 Mil) to Jun. 2024 ($1.66 Mil) and increased from Jun. 2024 ($1.66 Mil) to Sep. 2024 ($1.71 Mil).

Nanosphere Health Sciences's annual Total Liabilities increased from Dec. 2021 ($1.21 Mil) to Dec. 2022 ($1.37 Mil) and increased from Dec. 2022 ($1.37 Mil) to Dec. 2023 ($1.57 Mil).


Nanosphere Health Sciences Total Liabilities Historical Data

The historical data trend for Nanosphere Health Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Health Sciences Total Liabilities Chart

Nanosphere Health Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.25 1.51 1.21 1.37 1.57

Nanosphere Health Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 1.57 1.60 1.66 1.71

Nanosphere Health Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nanosphere Health Sciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.574+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=1.57

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=0.018--1.556
=1.57

Nanosphere Health Sciences's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.707+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=1.71

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=0.023--1.684
=1.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanosphere Health Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere Health Sciences Business Description

Traded in Other Exchanges
Address
1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.